Literature DB >> 16339072

Longitudinal analysis of Severe Acute Respiratory Syndrome (SARS) coronavirus-specific antibody in SARS patients.

Shan-Chwen Chang1, Jann-Tay Wang, Li-Min Huang, Yee-Chun Chen, Chi-Tai Fang, Wang-Huei Sheng, Jiun-Ling Wang, Chong-Jen Yu, Pan-Chyr Yang.   

Abstract

The serum antibodies to severe acute respiratory syndrome (SARS) coronavirus of 18 SARS patients were checked at 1 month and every 3 months after disease onset. All of them except one, who missed blood sampling at 1 month, tested positive for the immunoglobulin G (IgG) antibody at 1 month. Fifteen out of 17 tested positive for the IgM antibody at 1 month. The serum IgM antibody of most patients became undetectable within 6 months after the onset of SARS. The IgG antibody of all 17 patients, whose serum was checked 1 year after disease onset, remained positive.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339072      PMCID: PMC1317065          DOI: 10.1128/CDLI.12.12.1455-1457.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  14 in total

Review 1.  The severe acute respiratory syndrome.

Authors:  Joseph S M Peiris; Kwok Y Yuen; Albert D M E Osterhaus; Klaus Stöhr
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

2.  Profile of specific antibodies to the SARS-associated coronavirus.

Authors:  Gang Li; Xuejuan Chen; Anlong Xu
Journal:  N Engl J Med       Date:  2003-07-31       Impact factor: 91.245

Review 3.  Severe acute respiratory syndrome.

Authors:  Jann-Tay Wang; Shan-Chwen Chang
Journal:  Curr Opin Infect Dis       Date:  2004-04       Impact factor: 4.915

Review 4.  Severe acute respiratory syndrome.

Authors:  Michael D Christian; Susan M Poutanen; Mona R Loutfy; Matthew P Muller; Donald E Low
Journal:  Clin Infect Dis       Date:  2004-04-29       Impact factor: 9.079

5.  Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan.

Authors:  Po-Ren Hsueh; Cheng-Hsiang Hsiao; Shiou-Hwei Yeh; Wei-Kung Wang; Pei-Jer Chen; Jin-Town Wang; Shan-Chwen Chang; Chuan-Liang Kao; Pan-Chyr Yang
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

6.  Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes.

Authors:  Nigel J Temperton; Paul K Chan; Graham Simmons; Maria C Zambon; Richard S Tedder; Yasuhiro Takeuchi; Robin A Weiss
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

7.  SARS in hospital emergency room.

Authors:  Yee-Chun Chen; Li-Min Huang; Chang-Chuan Chan; Chan-Ping Su; Shan-Chwen Chang; Ying-Ying Chang; Mei-Ling Chen; Chien-Ching Hung; Wen-Jone Chen; Fang-Yue Lin; Yuan-Teh Lee
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

8.  Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients.

Authors:  Jann-Tay Wang; Wang-Huei Sheng; Chi-Tai Fang; Yee-Chun Chen; Jiun-Ling Wang; Chong-Jen Yu; Shan-Chwen Chang; Pan-Chyr Yang
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

9.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.

Authors:  J S M Peiris; C M Chu; V C C Cheng; K S Chan; I F N Hung; L L M Poon; K I Law; B S F Tang; T Y W Hon; C S Chan; K H Chan; J S C Ng; B J Zheng; W L Ng; R W M Lai; Y Guan; K Y Yuen
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

10.  Treatment of severe acute respiratory syndrome in health-care workers.

Authors:  Hsin-Yun Sun; Chi-Tai Fang; Jann-Tay Wang; Yee-Chun Chen; Shan-Chwen Chang
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

View more
  15 in total

1.  Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.

Authors:  F Javier Ibarrondo; Jennifer A Fulcher; David Goodman-Meza; Julie Elliott; Christian Hofmann; Mary A Hausner; Kathie G Ferbas; Nicole H Tobin; Grace M Aldrovandi; Otto O Yang
Journal:  N Engl J Med       Date:  2020-07-21       Impact factor: 91.245

2.  What is the long-term clinical significance of anti-SARS-CoV-2-specific IgG?

Authors:  Gabriela Gama Freire Alberca; Ricardo Wesley Alberca
Journal:  Influenza Other Respir Viruses       Date:  2020-11-01       Impact factor: 4.380

3.  Antibody response to SARS-CoV-2 in infected patients with different clinical outcome.

Authors:  Gabriele Anichini; Claudia Gandolfo; Chiara Terrosi; Simonetta Fabrizi; Giovanni Battista Miceli; Gianni Gori Savellini; Shibily Prathyumnan; Federico Franchi; Maria Grazia Cusi
Journal:  J Med Virol       Date:  2021-01-26       Impact factor: 2.327

Review 4.  Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic.

Authors:  Rehan M El-Shabasy; Mohamed A Nayel; Mohamed M Taher; Rehab Abdelmonem; Kamel R Shoueir; El Refaie Kenawy
Journal:  Int J Biol Macromol       Date:  2022-01-22       Impact factor: 6.953

5.  Duration of antibody responses after severe acute respiratory syndrome.

Authors:  Li-Ping Wu; Nai-Chang Wang; Yi-Hua Chang; Xiang-Yi Tian; Dan-Yu Na; Li-Yuan Zhang; Lei Zheng; Tao Lan; Lin-Fa Wang; Guo-Dong Liang
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

6.  Distinct Early Serological Signatures Track with SARS-CoV-2 Survival.

Authors:  Caroline Atyeo; Stephanie Fischinger; Tomer Zohar; Matthew D Slein; John Burke; Carolin Loos; Denise J McCulloch; Kira L Newman; Caitlin Wolf; Jingyou Yu; Kiel Shuey; Jared Feldman; Blake Marie Hauser; Tim Caradonna; Aaron G Schmidt; Todd J Suscovich; Caitlyn Linde; Yongfei Cai; Dan Barouch; Edward T Ryan; Richelle C Charles; Douglas Lauffenburger; Helen Chu; Galit Alter
Journal:  Immunity       Date:  2020-07-30       Impact factor: 31.745

Review 7.  Fc receptors in antibody-dependent enhancement of viral infections.

Authors:  Adam Taylor; Suan-Sin Foo; Roberto Bruzzone; Luan Vu Dinh; Nicholas J C King; Suresh Mahalingam
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

8.  Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset.

Authors:  Benny Borremans; Amandine Gamble; K C Prager; Sarah K Helman; Abby M McClain; Caitlin Cox; Van Savage; James O Lloyd-Smith
Journal:  Elife       Date:  2020-09-07       Impact factor: 8.140

9.  Simultaneous CD8+ T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs.

Authors:  Flavia Ferrantelli; Chiara Chiozzini; Francesco Manfredi; Andrea Giovannelli; Patrizia Leone; Maurizio Federico
Journal:  Vaccines (Basel)       Date:  2021-03-10

Review 10.  Immune response following infection with SARS-CoV-2 and other coronaviruses: A rapid review.

Authors:  Eamon O Murchu; Paula Byrne; Kieran A Walsh; Paul G Carty; Máire Connolly; Cillian De Gascun; Karen Jordan; Mary Keoghan; Kirsty K O'Brien; Michelle O'Neill; Susan M Smith; Conor Teljeur; Máirín Ryan; Patricia Harrington
Journal:  Rev Med Virol       Date:  2020-09-23       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.